Assessment of Interactions between Cisplatin and Two Histone Deacetylase Inhibitors in MCF7, T47D and MDA-MB-231 Human Breast Cancer Cell Lines - An Isobolographic Analysis.
Histone deacetylase inhibitors (HDIs) are promising anticancer drugs, which inhibit proliferation of a wide variety of cancer cells including breast carcinoma cells. In the present study, we investigated the influence of valproic acid (VPA) and suberoylanilide hydroxamic acid (SAHA, vorinostat), alo...
Main Authors: | Anna Wawruszak, Jarogniew J Luszczki, Aneta Grabarska, Ewelina Gumbarewicz, Magdalena Dmoszynska-Graniczka, Krzysztof Polberg, Andrzej Stepulak |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4651465?pdf=render |
Similar Items
-
Additive Pharmacological Interaction between Cisplatin (CDDP) and Histone Deacetylase Inhibitors (HDIs) in MDA-MB-231 Triple Negative Breast Cancer (TNBC) Cells with Altered Notch1 Activity—An Isobolographic Analysis
by: Anna Wawruszak, et al.
Published: (2019-07-01) -
Antagonistic Interaction between Histone Deacetylase Inhibitor: Cambinol and Cisplatin—An Isobolographic Analysis in Breast Cancer In Vitro Models
by: Marta Hałasa, et al.
Published: (2021-08-01) -
Histone deacetylase inhibitors – molecular mechanisms of actions and clinical applications
by: Aneta Grabarska, et al.
Published: (2013-08-01) -
Isobolographic Analysis Demonstrates the Additive and Synergistic Effects of Gemcitabine Combined with Fucoidan in Uterine Sarcomas and Carcinosarcoma Cells
by: Marcin Bobiński, et al.
Published: (2019-12-01) -
Proteomics Profiling of KAIMRC1 in Comparison to MDA-MB231 and MCF-7
by: Bandar Alghanem, et al.
Published: (2020-06-01)